Stockreport

TapImmune to Present at 2018 Sachs Associates Immuno-Oncology BD&L and Investment Forum

TAPIMMUNE INC COMMON  (TPIV) 
NASDAQ:AMEX Investor Relations: tapimmune.com/investors